首页> 外文期刊>Analytical chemistry >Differentiation of Deprotonated Acyl-, N-, and O-Glucuronide Drug Metabolites by Using Tandem Mass Spectrometry Based on Gas-Phase Ion-Molecule Reactions Followed by Collision-Activated Dissociation
【24h】

Differentiation of Deprotonated Acyl-, N-, and O-Glucuronide Drug Metabolites by Using Tandem Mass Spectrometry Based on Gas-Phase Ion-Molecule Reactions Followed by Collision-Activated Dissociation

机译:基于气相离子分子反应的串联质谱,通过抗阳离子分子反应,抗阳离子质谱,凝结活化解离

获取原文
获取原文并翻译 | 示例
           

摘要

Glucuronidation, a common phase II biotransformation reaction, is one of the major in vitro and in vivo metabolism pathways of xenobiotics. In this process, glucuronic acid is conjugated to a drug or a drug metabolite via a carboxylic acid, a hydroxy, or an amino group to form acyl-, O-, and/or N-glucuronide metabolites, respectively. This process is traditionally thought to be a detoxification pathway. However, some acyl-glucuronides react with biomolecules in vivo, which may result in immune-mediated idiosyncratic drug toxicity (IDT). In order to avoid this, one may attempt in early drug discovery to modify the lead compounds in such a manner that they then have a lower probability of forming reactive acyl-glucuronide metabolites. Because most drugs or drug candidates bear multiple functionalities, e.g., hydroxy, amino, and carboxylic acid groups, glucuronidation can occur at any of those. However, differentiation of isomeric acyl-, N-, and O-glucuronide derivatives of drugs is challenging. In this study, gas-phase ion molecule reactions between deprotonated glucuronide metabolites and BF3 followed by collision-activated dissociation (CAD) in a linear quadrupole ion trap mass spectrometer were demonstrated to enable the differentiation of acyl-, N-, and O-glucuronides. Only deprotonated N-glucuronides and deprotonated, migrated acyl-glucuronides form the two diagnostic product ions: a BF3 adduct that has lost two HF molecules, [M - H + BF3 - 2HF](-), and an adduct formed with two BF3 molecules that has lost three HF molecules, [M - H + 2BF(3) - 3HF](-). These product ions were not observed for deprotonated O-glucuronides and unmigrated, deprotonated acyl-glucuronides. Upon CAD of the [M - H + 2BF(3) - 3HF](-) product ion, a diagnostic fragment ion is formed via the loss of 2-fluoro-1,3,2-dioxaborale (MW of 88 Da) only in the case of deprotonated, migrated acyl-glucuronides. Therefore, this method can be used to unambiguously differentiate acyl-, N-, and O-glucuronides. Further, coupling this methodology with HPLC enables the differentiation of unmigrated 1-beta-acyl-glucuronides from the isomeric acyl-glucuronides formed upon acyl migration. Quantum chemical calculations at the M06-2X/6-311++G(d,p) level of theory were employed to probe the mechanisms of the reactions of interest.
机译:葡萄糖醛化,常见的II期生物转化反应,是异体中的主要和体内代谢途径。在该方法中,葡萄糖醛酸通过羧酸,羟基或氨基缀合与药物或药物代谢物,分别形成酰基,O-和/或N-葡糖醛酸代谢物。传统上,这个过程是一种排毒途径。然而,一些酰氨基葡萄糖醇与体内生物分子反应,这可能导致免疫介导的特质药物毒性(IDT)。为了避免这种情况,可以尝试早期药物发现以改性铅化合物,使得它们的形成具有较低的形成活性酰葡糖苷代谢物代谢物的概率。由于大多数药物或药物候选者承担多种功能,例如羟基,氨基和羧酸基团,可以在任何一种中发生血糖醛酸化。然而,药物的异构酰基,N-和O-葡糖苷衍生物的分化是挑战性的。在该研究中,对去质子化的葡萄糖醛酸酯代谢物和BF3之间的气相离子分子反应,然后在线性四极离子阱质谱仪中进行碰撞活化的解离(CAD),以使酰基,N-和O-葡糖醛酸酯的分化。仅取代的N-葡糖苷糖苷和脱质,迁移乙酰葡糖苷酰胺,形成两个诊断产物离子:丢失了两个HF分子的BF 3加合物,[M - H + BF3 - 2HF]( - ),以及用两个BF3分子形成的加合物已经丢失了三个HF分子,[M - H + 2BF(3) - 3HF]( - )。未观察到去质子化的O-葡糖醛糖苷并非解压缩酰基 - 葡糖醛糖苷的这些产物离子。在[M - H + 2BF(3) - 3HF]( - )产物离子的CAD后,通过仅损失2-Fluoro-1,3,2-DioxaBorale(MW为88Da),形成诊断片段离子在质子化的情况下,迁移的酰氨基醛糖苷迁移。因此,该方法可用于明确地分化酰基,N-和O-葡糖苷。此外,通过HPLC偶联该方法使得未取代的1-β-酰基 - 葡糖苷酰胺与在酰基迁移上形成的异构酰基葡糖醛糖苷的分化能够分化。 M06-2X / 6-311 ++ G(D,P)理论水平的量子化学计算探讨了感兴趣的反应的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号